ENTRY       D04148                      Drug
NAME        Fenfluramine hydrochloride (JAN/USAN);
            Fintepla (TN);
            Pondimin (TN)
PRODUCT     FINTEPLA (UCB)
FORMULA     C12H16F3N. HCl
EXACT_MASS  267.1002
MOL_WEIGHT  267.7183
CLASS       Gastrointestinal agent
             DG01705  Anoretic
              DG01704  Phenethylamine anorexic
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG02919  CYP2B6 substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
REMARK      Therapeutic category: 1139
            ATC code: A08AA02 N03AX26
            Chemical structure group: DG00103
            Product (DG00103): D04148<JP/US>
EFFICACY    Antiepileptic, Appetite suppressant
  DISEASE   Dravet syndrome [DS:H01818]
            Lennox-Gastaut syndrome [DS:H01813]
TARGET      SLC6A4 (HTT) [HSA:6532] [KO:K05037]
            HTR1D [HSA:3352] [KO:K04153]
            HTR2A [HSA:3356] [KO:K04157]
            HTR2C [HSA:3358] [KO:K04157]
            SIGMAR1 [HSA:10280] [KO:K20719]
  PATHWAY   hsa04080(3352+3356+3358)  Neuroactive ligand-receptor interaction
            hsa04726(3352+3356+3358+6532)  Serotonergic synapse
            hsa05022(10280)  Pathways of neurodegeneration - multiple diseases
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP2B6 [HSA:1555], CYP2D6 [HSA:1565]; CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
               A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
                A08AA Centrally acting antiobesity products
                 A08AA02 Fenfluramine
                  D04148  Fenfluramine hydrochloride (JAN/USAN) &lt;JP/US&gt;
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AX Other antiepileptics
                 N03AX26 Fenfluramine
                  D04148  Fenfluramine hydrochloride (JAN/USAN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               113  Antiepileptics
                1139  Others
                 D04148  Fenfluramine hydrochloride (JAN/USAN)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01705  Anoretic
               DG01704  Phenethylamine anorexic
                DG00103  Fenfluramine
                 D04148  Fenfluramine hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00103  Fenfluramine
                D04148  Fenfluramine hydrochloride
              DG02919  CYP2B6 substrate
               DG00103  Fenfluramine
                D04148  Fenfluramine hydrochloride
              DG01642  CYP2C9 substrate
               DG00103  Fenfluramine
                D04148  Fenfluramine hydrochloride
              DG01639  CYP2C19 substrate
               DG00103  Fenfluramine
                D04148  Fenfluramine hydrochloride
              DG01644  CYP2D6 substrate
               DG00103  Fenfluramine
                D04148  Fenfluramine hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00103  Fenfluramine
                 D04148  Fenfluramine hydrochloride
              DG02925  CYP3A5 substrate
               DG00103  Fenfluramine
                D04148  Fenfluramine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Serotonin
                HTR1D
                 D04148  Fenfluramine hydrochloride (JAN/USAN) &lt;JP/US&gt;
                HTR2A
                 D04148  Fenfluramine hydrochloride (JAN/USAN) &lt;JP/US&gt;
                HTR2C
                 D04148  Fenfluramine hydrochloride (JAN/USAN) &lt;JP/US&gt;
             Transporters
              Solute carrier family
               SLC6
                SLC6A4 (HTT)
                 D04148  Fenfluramine hydrochloride (JAN/USAN) &lt;JP/US&gt;
              Other transporters
               Auxiliary transport proteins (TC:8.A)
                SIGMAR1
                 D04148  Fenfluramine hydrochloride (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04148
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04148
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04148
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04148
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01705  Anoretic
               DG01704  Phenethylamine anorexic
                DG00103  Fenfluramine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00103  Fenfluramine
              DG02919  CYP2B6 substrate
               DG00103  Fenfluramine
              DG01642  CYP2C9 substrate
               DG00103  Fenfluramine
              DG01639  CYP2C19 substrate
               DG00103  Fenfluramine
              DG01644  CYP2D6 substrate
               DG00103  Fenfluramine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00103  Fenfluramine
              DG02925  CYP3A5 substrate
               DG00103  Fenfluramine
DBLINKS     CAS: 404-82-0
            PubChem: 47206095
            ChEBI: 59729
            LigandBox: D04148
            NIKKAJI: J349.650C
ATOM        17
            1   C8y C    16.3100  -16.0300
            2   C8x C    15.1200  -15.3300
            3   C8x C    16.3100  -17.4300
            4   C1b C    17.5000  -15.3300
            5   C8y C    13.8600  -16.0300
            6   C8x C    15.1200  -18.1300
            7   C1c C    18.7600  -16.0300
            8   C8x C    13.8600  -17.4300
            9   C1d C    12.6700  -15.3300
            10  N1b N    19.9500  -15.3300
            11  C1a C    18.7600  -17.4300
            12  X   F    11.3400  -14.5600
            13  X   F    12.0400  -16.3800
            14  X   F    13.4400  -14.2100
            15  C1b C    21.2100  -16.0300
            16  C1a C    22.4000  -15.3300
            17  X   Cl   23.3100  -17.7800
BOND        16
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     5   8 2
            8     5   9 1
            9     7  10 1
            10    7  11 1
            11    9  12 1
            12    9  13 1
            13    9  14 1
            14   10  15 1
            15   15  16 1
            16    6   8 1
///
